Bovine β-Casein (1−28), a Casein Phosphopeptide, Enhances Proliferation and IL-6 Expression of Mouse CD19+ Cells via Toll-like Receptor 4

This study was conducted to elucidate the target cells and receptors which participate in the mitogenic and interleukin (IL)-6-enhancing effect of bovine β-casein (1−28), a casein phosphopeptide. When the spleen lymphocyte subset (CD4+, CD8+, and CD19+ cells) from C3H/HeN mice was cultured with the...

Full description

Saved in:
Bibliographic Details
Published inJournal of agricultural and food chemistry Vol. 54; no. 21; pp. 8013 - 8017
Main Authors Tobita, Keisuke, Kawahara, Takeshi, Otani, Hajime
Format Journal Article
LanguageEnglish
Published Washington, DC American Chemical Society 18.10.2006
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This study was conducted to elucidate the target cells and receptors which participate in the mitogenic and interleukin (IL)-6-enhancing effect of bovine β-casein (1−28), a casein phosphopeptide. When the spleen lymphocyte subset (CD4+, CD8+, and CD19+ cells) from C3H/HeN mice was cultured with the β-casein (1−28), it exerted a dose-dependent mitogenic effect on CD19+ cells. The effect of β-casein (1−28) was not apparent in the case of CD19+ cells from C3H/HeJ mouse. In addition, the effect was significantly inhibited by treating the C3H/HeN mouse-derived CD19+ cells with neutralizing antibody for toll-like receptor 4 (TLR4). Reverse transcription-polymerase chain reaction analysis showed that the β-casein (1−28) exerted an IL-6-enhancing effect on the CD19+ cells. The effect was also abrogated in either C3H/HeJ mouse-derived CD19+ cell culture or the anti-TLR4 antibody-added culture. These results suggest that the β-casein (1−28) stimulates both proliferation and IL-6 expression of CD19+ cells via TLR4. Keywords: Casein phosphopeptide; milk; mitogenic activity; CD19+ cells; IL-6; toll-like receptor 4
Bibliography:istex:DC73C1B8A33DF97539BD802B352CEA9B6DDAD665
ark:/67375/TPS-GV9769XZ-8
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-8561
1520-5118
DOI:10.1021/jf0610864